Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Visen Pharma Approved for China Phase III Trial of Growth Hormone Drug

publication date: Oct 28, 2019

Visen Pharma of Shanghai reported that China approved its IND to start a Phase III trial for TransCon human growth hormone in patients with childhood growth hormone deficiency (GHD). Visen was formed last year by Sweden's Ascendis Pharma and an investor syndicate that provided $40 million in capital, led by Vivo Capital. The company will develop Ascendis' portfolio of three endocrinology rare disease therapies in Greater China. Visen believes TransCon hGH, a long-acting drug that offers once-weekly dosing, will be the first long-acting growth hormone therapy available in China. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here